Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel with Radiation for High Risk Prostate Cancer
NCT01603420Phase 3Terminated
- Sponsor
- Proton Collaborative Group
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in prostate adenocarcinoma, sponsored by Proton Collaborative Group. Started Jul 2012; status: terminated.
02
Drugs
docetaxel
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT01603420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603420.